Posted by Michael Wonder on 30 Apr 2021
FDA approves higher dosage of naloxone nasal spray to treat opioid overdose
30 April 2021 - The U.S. FDA announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.
The newly approved product delivers 8 mg of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.
